drugset / Trial / NCT06206720
A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the safety, efficacy, pharmacokinetic (PK) characteristics and antiviral activity of different doses of Deuterium Hydrobromide for suspension in the treatment of respiratory syncytial virus infection in infants.
Timeline
- Start
- 2024-01-31
- Primary completion
- 2025-06-16
- Completion
- 2025-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REMIDEVIR | Small molecule | 15 mg/kg | Oral |
| Subject | REMIDEVIR | Small molecule | 20 mg/kg | Oral |